- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07653178
Predicting Allograft Volume in Orthopedic Oncology: Hemielipsoid Formula vs Intraoperative Fluid-Fill Measurement (PREDALL)
Preoperative Bone Defect Volume Estimation Using the Hemielipsoid Formula for Allograft Planning in Musculoskeletal Tumor Surgery: A Prospective Validation Study Against Intraoperative Fluid Displacement Measurement
Bone defects following primary musculoskeletal tumor resection are frequently reconstructed using structural allografts. Allograft availability is limited, and intraoperative waste due to oversized graft selection remains a practical challenge in orthopedic oncology. Accurate preoperative estimation of the expected defect volume is therefore critical not only for surgical planning but also for minimizing unnecessary allograft use.
This prospective study aims to evaluate the accuracy of the preoperative hemielipsoid formula in estimating bone defect volume after primary musculoskeletal tumor resection, using intraoperative fluid displacement as the reference standard. A secondary aim is to determine whether preoperative CT-based hemielipsoid volume calculation can reliably guide allograft selection and reduce intraoperative graft waste.
Patients scheduled for primary musculoskeletal tumor resection with structural allograft reconstruction at Sakarya University Training and Research Hospital will be enrolled. Preoperative defect volume will be estimated using the hemielipsoid formula (V = 4/3 × π × a × b × c / 2) derived from preoperative CT measurements. Intraoperative defect volume will be measured by fluid displacement as the reference standard. Agreement between methods will be assessed by Bland-Altman analysis and intraclass correlation coefficient (ICC).
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
**Background:** In orthopedic oncology, structural allograft reconstruction following primary musculoskeletal tumor resection requires precise preoperative planning. Currently, allograft selection at our institution relies on the surgeon's intraoperative visual estimation, with no standardized preoperative volumetric assessment protocol in place. This approach may result in allograft waste due to oversized graft selection, which is particularly problematic given the limited availability of allograft bank resources.
**Rationale:** The hemielipsoid formula (V = 4/3 × π × a × b × c / 2) offers a simple, reproducible method for estimating irregular bone defect volumes from standard cross-sectional imaging. If validated against an intraoperative reference standard, this formula could serve as a practical preoperative planning tool to guide allograft selection and minimize unnecessary graft use.
**Study Design:** This is a single-center prospective observational study conducted at Sakarya University Training and Research Hospital, Department of Orthopedics and Traumatology.
**Preoperative Assessment:** Defect volume will be estimated by the operating surgeon using the hemielipsoid formula applied to routine preoperative CT imaging. The three principal dimensions of the anticipated resection defect (length, width, and depth) will be measured on axial, coronal, and sagittal CT reconstructions, and volume will be calculated accordingly.
**Intraoperative Assessment:** Following tumor resection, the actual bone defect volume will be measured by direct cavity fluid displacement as the intraoperative reference standard. The resection cavity will be filled with a measured volume of saline to determine the true defect volume.
**Outcome Assessment:** The primary outcome is the agreement between preoperative hemielipsoid-estimated volume and intraoperative fluid displacement-measured volume, assessed by Bland-Altman analysis and intraclass correlation coefficient (ICC). The secondary outcome is the correlation between preoperative volume estimation and actual allograft volume used, to evaluate the utility of the hemielipsoid formula in reducing intraoperative allograft waste.
**Sample Size:** A priori power analysis was performed based on intraclass correlation coefficient (ICC) estimation (H0: ICC = 0.70; H1: ICC = 0.90; two-tailed alpha = 0.05; power = 0.80) using the Fisher z-transformation method, indicating a minimum required sample size of 25 patients. Target enrollment was set at 40 patients to account for a 10% dropout rate and to allow for potential subgroup analyses.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Lieux d'étude
-
-
-
Sakarya, Turquie (Türkiye)
- Sakarya University Training and Research Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Patients diagnosed with a primary musculoskeletal tumor requiring surgical resection
- Structural allograft reconstruction planned following resection
- Routine preoperative CT imaging available for hemielipsoid measurements
- Age ≥ 18 years
- Written informed consent obtained
Exclusion Criteria:
- Metastatic bone tumors
- Pathological fracture at the resection site precluding accurate volume estimation
- Prior surgery at the same anatomical site
- Unavailability of adequate preoperative CT imaging
- Reconstruction planned with implant or autograft only (no structural allograft)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Hemielipsoid Volume Estimation Group
atients undergoing primary musculoskeletal tumor resection with structural allograft reconstruction.
Preoperative bone defect volume is estimated using the hemielipsoid formula from CT imaging.
Intraoperative defect volume is measured by saline cavity fill displacement as the reference standard.
|
Preoperative bone defect volume is estimated by the operating surgeon using the hemielipsoid formula (V = 4/3 × π × a × b × c / 2) applied to routine preoperative CT imaging.
The three principal dimensions of the anticipated resection defect are measured on axial, coronal, and sagittal CT reconstructions.
Intraoperative defect volume is measured by saline cavity fill displacement as the reference standard.
No additional procedures beyond standard surgical care are performed.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Agreement between preoperative hemielipsoid-estimated and intraoperative fluid displacement-measured bone defect volume
Délai: Intraoperative (Day 1)
|
Assessed by Bland-Altman analysis and intraclass correlation coefficient (ICC) between the two volumetric measurement methods
|
Intraoperative (Day 1)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Allograft waste volume
Délai: Intraoperative (Day 1)
|
Difference between allograft volume prepared and actual volume used, compared between hemielipsoid-guided and historical surgeon estimation
|
Intraoperative (Day 1)
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- E-43012747-050.04-543070-646
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .